- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sun Pharma Advanced Research Company Ltd (SPRC)
Sun Pharma Advanced Research Company Ltd stock price live, this page displays NSE SPRC stock exchange data. View the SPRC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sun Pharma Advanced Research Company Ltd real time stock price chart below.
What Is the Sun Pharma Advanced Research Company Ltd Stock Price Today?
The Sun Pharma Advanced Research Company Ltd stock price today is 264.60.
What Is the Stock Symbol for Sun Pharma Advanced Research Company Ltd?
The stock symbol for Sun Pharma Advanced Research Company Ltd is "SPRC."
What Stock Exchange Does Sun Pharma Advanced Research Company Ltd Trade On?
Sun Pharma Advanced Research Company Ltd is listed and trades on the NSE stock exchange.
Is Sun Pharma Advanced Research Company Ltd a Good Stock to Buy?
Determining whether Sun Pharma Advanced Research Company Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SPRC quote. (ISIN: INE232I01014)
What Is the Sun Pharma Advanced Research Company Ltd Stock Price Today?
The Sun Pharma Advanced Research Company Ltd stock price today is 264.60.
What Is the Stock Symbol for Sun Pharma Advanced Research Company Ltd?
The stock symbol for Sun Pharma Advanced Research Company Ltd is "SPRC."
What Stock Exchange Does Sun Pharma Advanced Research Company Ltd Trade On?
Sun Pharma Advanced Research Company Ltd is listed and trades on the NSE stock exchange.
Is Sun Pharma Advanced Research Company Ltd a Good Stock to Buy?
Determining whether Sun Pharma Advanced Research Company Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SPRC quote. (ISIN: INE232I01014)
264.60
-12.97(-4.67%)
Closed·
Fair Value
An estimate of a Sun Pharma Adv. Research's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
258.62
280.50
52 wk Range
108.00
289.00
SPRC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Sun Pharma Adv. Research's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
258.62280.50
52 wk Range
108.00289.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SPRC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Sun Pharma Adv. Research's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
2,000.00
Upside
+655.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 2,000.00
(+655.86% Upside)
Earnings
Latest Release
May 18, 2026
EPS / Forecast
54.27 / --
Revenue / Forecast
18.55B / --
Compare SPRC to Peers and Sector
Metrics to compare | SPRC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSPRCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 5.5x | 39.8x | −0.4x | |
PEG Ratio | 0.01 | 0.10 | 0.00 | |
Price/Book | 6.4x | 2.2x | 2.6x | |
Price / LTM Sales | 219.3x | 1.5x | 3.0x | |
Upside (Analyst Target) | - | 15.0% | 51.7% | |
Fair Value Upside | Unlock | 12.8% | 8.8% | Unlock |
Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology and immunology. The company is also developing Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. In addition, it develops SCD-153 for the treatment of alopecia areata; and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sun Pharma Adv. Research (SPRC) Stock Price Today?
The Sun Pharma Adv. Research stock price today is 264.60 INR.
What Stock Exchange Does Sun Pharma Adv. Research Trade On?
Sun Pharma Adv. Research is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Sun Pharma Adv. Research?
The stock symbol for Sun Pharma Adv. Research is "SPRC."
What Is the Sun Pharma Adv. Research Market Cap?
As of today, Sun Pharma Adv. Research market cap is 85.87B INR.
What Is Sun Pharma Adv. Research's Earnings Per Share (TTM)?
The Sun Pharma Adv. Research EPS (TTM) is 47.86.
From a Technical Analysis Perspective, Is SPRC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sun Pharma Adv. Research Stock Split?
Sun Pharma Adv. Research has split 2 times.
How Many Employees Does Sun Pharma Adv. Research Have?
Sun Pharma Adv. Research has 316 employees.
What is the current trading status of Sun Pharma Adv. Research (SPRC)?
As of Jul 12, 2026, Sun Pharma Adv. Research (SPRC) is trading at a price of 264.60 INR, with a previous close of 277.57 INR. The stock has fluctuated within a day range of 258.62 INR to 280.50 INR, while its 52-week range spans from 108.00 INR to 289.00 INR.
What Is Sun Pharma Adv. Research (SPRC) Price Target According to Analysts?
The average 12-month price target for Sun Pharma Adv. Research is 2,000.00 INR, with a high estimate of 2000 INR and a low estimate of 2000 INR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +655.86% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.